agilon health’s (AGL) Hold Rating Reiterated at Needham & Company LLC

agilon health (NYSE:AGL)‘s stock had its “hold” rating restated by equities researchers at Needham & Company LLC in a note issued to investors on Friday,Benzinga reports.

Other research analysts also recently issued reports about the stock. Sanford C. Bernstein raised their price objective on shares of agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research report on Wednesday, January 15th. Macquarie began coverage on shares of agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 price objective on the stock. Stifel Nicolaus lifted their target price on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a report on Wednesday, February 26th. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and lifted their target price for the company from $1.75 to $2.25 in a report on Friday, January 10th. Finally, Royal Bank of Canada lifted their target price on shares of agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a report on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, agilon health currently has a consensus rating of “Hold” and a consensus price target of $3.95.

agilon health Trading Down 6.9 %

Shares of agilon health stock opened at $4.10 on Friday. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market capitalization of $1.69 billion, a P/E ratio of -4.36 and a beta of 0.67. The company’s fifty day moving average is $3.47 and its two-hundred day moving average is $2.95.

Institutional Trading of agilon health

A number of institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after acquiring an additional 272,787 shares during the last quarter. Capital International Investors increased its position in agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after acquiring an additional 9,346,295 shares during the period. State Street Corp increased its position in agilon health by 3.0% during the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after acquiring an additional 215,733 shares during the period. Millennium Management LLC increased its holdings in agilon health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after buying an additional 4,706,357 shares during the period. Finally, Geode Capital Management LLC increased its holdings in agilon health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after buying an additional 35,207 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.